Pulmonx (LUNG) Total Liabilities (2019 - 2025)

Pulmonx (LUNG) has 7 years of Total Liabilities data on file, last reported at $75.2 million in Q4 2025.

• Quarterly Total Liabilities fell 2.42% year-over-year to $75.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $75.2 million (down 2.42% YoY) and the FY2025 annual result came in at $75.2 million, down 2.42% from the prior year.
• Total Liabilities retreated to $75.2 million in Q4 2025 per LUNG's latest filing, from $78.2 million in the prior quarter.
• Across five years, Total Liabilities topped out at $78.2 million in Q3 2025 and bottomed at $38.7 million in Q3 2022.
• The 5-year median for Total Liabilities is $58.2 million (2023), against an average of $57.0 million.
• The widest annual swing landed in 2021, when Total Liabilities slumped 80.53%; it then surged 53.08% in 2023.
• Tracing LUNG's Total Liabilities over 5 years: stood at $41.9 million in 2021, then retreated by 5.4% to $39.7 million in 2022, then surged by 49.91% to $59.5 million in 2023, then grew by 29.55% to $77.0 million in 2024, then slipped by 2.42% to $75.2 million in 2025.
• Per Business Quant, the three latest LUNG Total Liabilities figures stand at $75.2 million (Q4 2025), $78.2 million (Q3 2025), and $78.1 million (Q2 2025).

Peer Comparison